Symbol="KDNY"
AssetType="Common Stock"
Name="Chinook Therapeutics Inc"
Description="Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision drugs for kidney disease. The company is headquartered in Seattle, Washington."
CIK="1435049"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="740 HEINZ AVENUE, BERKELEY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2608226000"
EBITDA="-197027008"
PERatio="None"
PEGRatio="None"
BookValue="6.17"
DividendPerShare="0"
DividendYield="0"
EPS="-3.22"
RevenuePerShareTTM="0.078"
ProfitMargin="0"
OperatingMarginTTM="-38.44"
ReturnOnAssetsTTM="-0.235"
ReturnOnEquityTTM="-0.516"
RevenueTTM="5259000"
GrossProfitTTM="-135083000"
DilutedEPSTTM="-3.22"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.322"
AnalystTargetPrice="39.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="27.9"
PriceToBookRatio="3.057"
EVToRevenue="19.67"
EVToEBITDA="-11.5"
Beta="0.683"
num_52WeekHigh="39.54"
num_52WeekLow="17.72"
num_50DayMovingAverage="31.83"
num_200DayMovingAverage="24.97"
SharesOutstanding="67050000"
DividendDate="2020-10-02"
ExDividendDate="None"
symbol="KDNY"
open="39.05"
high="39.37"
low="38.95"
price="39.25"
volume="506260.00"
latest_trading_day="2023-07-24"
previous_close="38.90"
change="0.35"
change_percent="0.8997%"
aroon_positive_momentum_days="37"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="37"
Volume_recent_avg="1113129"
Change_recent_avg="0.02"
Delta_recent_avg="0.85"
Variance_recent_avg="0.42"
Change_ratio_recent_avg="0.06"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="37"
Aroon_momentum_negative="63"
image_negative_thumbnail_id_1="1118"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0151.jpeg"
image_negative_thumbnail_id_2="147"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0029.jpeg"
image_neutral_thumbnail_id_1="576"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_neutral_thumbnail_id_2="530"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0069.jpeg"
image_positive_thumbnail_id_1="644"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0064.jpeg"
image_positive_thumbnail_id_2="984"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0146.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1179"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
